LONDON, Dec 2 (Reuters) - Britain's medical regulator
assessed the Pfizer/BioNTech vaccine according to international
standards and within the provisions of European law, its chief
executive said on Wednesday.
"The way in which the MHRA has worked is equivalent to all
international standards," June Raine said.
Asked about whether Britain's departure from the European
Union earlier this year had affected the speed of the
authorisation, Raine said that the regulator had used provisions
of European law, which apply until the end of the year when a
Brexit transition period ends.
"We have been able to authorise the supply of this vaccine
using provisions under European law, which exist until (Jan. 1).
Our progress has been totally dependent on the availability of
data in our rolling review and the rigorous assessment and
independent advice we have received," Raine said.
(Reporting by Guy Faulconbridge and Kate Holton, writing by
Alistair Smout, editing by Estelle Shirbon)
Astrazeneca (AZN)